Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice.
2012
AVEO Pharmaceuticals, Cambridge, MA 02139. Novartis Institute for Biomedical Research, Cambridge, MA 02139. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229-3039. Independent Consultant, Gettysburg, PA 17325. Independent Consultant, Natick, MA 01760. To whom correspondence should be addressed at Biologics Research and Development, Genzyme Corporation, 5 Mountain Road, Framingham, MA 01701-9322. Fax: (508) 661-1854. E-mail: laura.andrews@genzyme.com.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
30
References
25
Citations
NaN
KQI